Effects of Elamipretide on Left Ventricular Function in Patients with Heart Failure with Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial

The objective of this study was to evaluate the effects of multiple subcutaneous doses of elamipretide on left ventricular end systolic volume (LVESV) assessed by cardiac magnetic resonance imaging (MRI).

Source: Journal of Cardiac Failure - February 13, 2020 Category: Cardiology Authors: Javed Butler, Muhammad Shahzeb Khan, Stefan D. Anker, Gregg C. Fonarow, Raymond J. Kim, Savina Nodari, Christopher M. O'Connor, Burkert Pieske, Elisabeth Pieske-Kraigher, Hani N. Sabbah, Michele Senni, Adriaan A. Voors, James E. Udelson, Jim Carr, Mihai G Source Type: research